Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
2.530
-0.140 (-5.24%)
At close: Nov 21, 2024, 4:00 PM
2.600
+0.070 (2.77%)
After-hours: Nov 21, 2024, 5:54 PM EST
Sutro Biopharma Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$12.14
Upside
+379.84%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +374.31% | Nov 18, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $11 | Buy | Reiterates | $11 | +334.78% | Oct 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +374.31% | Oct 11, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +571.94% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +374.31% | Sep 16, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $18 → $15 | Strong Buy | Maintains | $18 → $15 | +492.89% | Aug 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +374.31% | Aug 14, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +295.26% | May 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +374.31% | May 14, 2024 |
| Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +216.21% | May 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +374.31% | May 8, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $17 | Buy | Reiterates | $17 | +571.94% | Apr 3, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 → $11 | Buy | Reiterates | $12 → $11 | +334.78% | Apr 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +295.26% | Apr 3, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $25 → $18 | Strong Buy | Maintains | $25 → $18 | +611.46% | Apr 3, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +295.26% | Mar 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.